YD Bio Says Partner EG Biomed Receives College of American Pathologists Accreditation
MT Newswires Live
Oct 10
YD Bio (YDES) said Friday that its business partner EG Biomed US has received College of American Pathologists accreditation for its CLIA-certified laboratory in Bothell, Washington.
The accreditation is considered the gold standard in laboratory quality assurance and confirms that EG Biomed meets the standards of excellence in lab operations, the company said.
EG Biomed is one of YD Bio's licensing partners for pancreatic and breast cancer detection and with 3D Global to develop eye disorder therapies, according to the biotechnology company.
Shares of YD Bio were up more than 12% in recent Friday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.